233 related articles for article (PubMed ID: 4151131)
21. [Adrenergic receptor drugs in treatment of shock].
Huguenard P
Laval Med; 1971 Sep; 42(7):8638-40. PubMed ID: 4398770
[No Abstract] [Full Text] [Related]
22. [Basic principles of shock therapy].
Schröder R
Dtsch Med Wochenschr; 1971 Jan; 96(4):167-9. PubMed ID: 5539531
[No Abstract] [Full Text] [Related]
23. The effect of alpha and beta adrenergic blockade on thoracic duct lymph flow in normovolemic and hypovolemic dogs.
Nelson NC; Nelson JL; Vela AR; Soler F
Am Surg; 1969 Dec; 35(12):851-5. PubMed ID: 4390978
[No Abstract] [Full Text] [Related]
24. Overview of shock.
Majerus TC
Arch Int Physiol Biochim; 1984 Nov; 92(4):S1-4. PubMed ID: 6085235
[No Abstract] [Full Text] [Related]
25. [Basic principles of the therapy of shock].
Schröder R
Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
[No Abstract] [Full Text] [Related]
26. [The treatment of shock with isoproterenol].
Gigon JP; Wolff G; Enderlin F
Schweiz Med Wochenschr; 1966 May; 96(18):597-603. PubMed ID: 4296045
[No Abstract] [Full Text] [Related]
27. Adrenergic agonists and antagonists in the treatment of hypovolemic shock.
Williamson M
J Am Med Womens Assoc; 1969 Dec; 24(12):951-6 passim. PubMed ID: 4391032
[No Abstract] [Full Text] [Related]
28. [1st experiences with the clinical use of dopamine in the treatment of shock].
Lotto A; Lomanto B; Bossi M
Boll Soc Ital Cardiol; 1971; 16(9):601-5. PubMed ID: 5150386
[No Abstract] [Full Text] [Related]
29. Catecholamines in critical care.
Maddens M; Sowers J
Crit Care Clin; 1987 Oct; 3(4):871-82. PubMed ID: 3332227
[TBL] [Abstract][Full Text] [Related]
30. Direct binding studies of adrenergic receptors: biochemical, physiologic, and clinical implications.
Lefkowitz RJ
Ann Intern Med; 1979 Sep; 91(3):450-8. PubMed ID: 38720
[TBL] [Abstract][Full Text] [Related]
31. [1st clinical studies in therapy of shock with ornithine-8-vasopressin (POR-8)].
Alsweiler W; Opderbecke HW
Z Prakt Anasth; 1970 Apr; 5(2):91-104. PubMed ID: 4256223
[No Abstract] [Full Text] [Related]
32. [The use of sympathomimetics and sympatholytics in shock].
Torsti P
Duodecim; 1971; 87(4):297-304. PubMed ID: 5547048
[No Abstract] [Full Text] [Related]
33. New advances in the pharmacologic approach to circulatory shock.
Chernow B
J Clin Anesth; 1996 May; 8(3 Suppl):67S-69S. PubMed ID: 8695118
[No Abstract] [Full Text] [Related]
34. Indications for adrenergic stimulators in shock.
Mills LC; Moyer JH
Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
[No Abstract] [Full Text] [Related]
35. [Adrenergic receptor mechanism of the human uterus].
Soto-Baca L
Rev Esp Fisiol; 1971 Mar; 27(1):1-7. PubMed ID: 4397992
[No Abstract] [Full Text] [Related]
36. The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock.
Lillehei RC; Dietzman RH; Motsay GJ; Schultz LS; Romero LH; Beckman CB
Geriatrics; 1972 Jul; 27(7):73-83. PubMed ID: 5039885
[No Abstract] [Full Text] [Related]
37. [Attempted criticism of the endotoxic theory of the pathogenesis of experimental shock].
Novelli GP; Cortesini C; Pagliai P; Francini R; Pagni E
Policlinico Chir; 1969; 76(5):277-301. PubMed ID: 4391427
[No Abstract] [Full Text] [Related]
38. Adrenergic blockade and glucoregulation in endotoxin shock.
Filkins JP
Circ Shock; 1979; 6(2):99-107. PubMed ID: 36999
[No Abstract] [Full Text] [Related]
39. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
Wiśniewska RJ
Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of shock].
Pichlmayr I
Fortschr Med; 1971 Jul; 89(19):819-22. PubMed ID: 4403733
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
